India's drugs regulator on Saturday recommended for emergency use a locally developed coronavirus vaccine called COVAXIN, which is expected to be a backup to the AstraZeneca/Oxford shot.
New Delhi [India], January 3 (ANI): With COVID-19 vaccines of Serum Institue of India and Bharat Biotech being granted permission for restricted use in an emergency situation, Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey on Sunday stated that India will become corona-free.
Whenever India achieves something, Cong comes up with wild theories to ridicule accomplishments: Nadda ANI | Updated: Jan 03, 2021 20:44 IST
New Delhi [India], January 3 (ANI): Bharatiya Janata Party (BJP) national president JP Nadda on Sunday slammed the Congress and other opposition parties for questioning India s drug regulator s approval to two COVID-19 vaccines for restricted emergency use in the country.
Taking to Twitter, the BJP chief said that Congress comes up with wild theories whenever India achieves something commendable. Time and again we have seen whenever India achieves something commendable - that will further public good - the Congress comes up with wild theories to oppose and ridicule the accomplishments. The more they oppose, the more they are exposed. The latest example is the Covid vaccines, Nadda said in a tweet.
Premature, could be dangerous : Shashi Tharoor questions approval for Covaxin without phase 3 trials dtnext.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dtnext.in Daily Mail and Mail on Sunday newspapers.
COVID-19 vaccines of SII, Bharat Biotech approved for restricted use in emergency situation ANI | Updated: Jan 03, 2021 11:36 IST
New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday. After adequate examination, CDSCO has decided to accept the recommendations of the Expert Committee and accordingly, vaccines of M/s Serum and M/s Bharat Biotech are being approved for restricted use in emergency situation and permission is being granted to M/s Cadila Healthcare for conduct of the Phase III clinical trial, said VG Somani, DCGI, during a media briefing today.